Literature DB >> 1623013

Opsonophagocytosis of liposomes by peritoneal macrophages and bone marrow reticuloendothelial cells.

S M Moghimi1, H M Patel.   

Abstract

We investigated the opsonic effect of serum on the phagocytosis of cholesterol-poor and cholesterol-rich liposomes with freshly prepared rat bone marrow and peritoneal phagocytes in suspension. The presence of serum in incubation increased the uptake of cholesterol-rich but not cholesterol-poor liposomes in bone marrow cells, whereas serum enhances phagocytosis of both liposome preparations in peritoneal phagocytes. The opsonic activity of serum on the uptake of liposomes by both cell types is destroyed by heat, ammonium hydroxide, and zymosan treatments of serum, which suggests the involvement of complement in phagocytosis of liposomes. However, bone marrow cells and peritoneal macrophages responded differently when incubated with dialysed or EGTA-chelated serum. These treatments result in complete loss of the opsonic effect of serum on the uptake of liposome in bone marrow cells. Addition of serum dialysate or divalent cations to dialysed serum do not reinstall its lost opsonic activity. Thus these results shade doubt on possibility of involvement of complements in phagocytosis of liposomes by bone marrow cells. Dialysed or EGTA-treated serum also failed to promote liposome uptake by peritoneal macrophages but unlike in the case of bone marrow cells replacement of divalent cations to such sera reinstalls its opsonic activity and enhances phagocytosis of liposomes by peritoneal macrophages. These observations suggest the involvement of different serum components on liposome uptake by bone marrow cells and peritoneal macrophages, and emphasize the complexities associated with RES-mediated blood clearance of the intravenously injected liposomes. The properties of these opsonins are compared with those of 'liver-' and 'spleen-specific' opsonins responsible for phagocytosis of liposomes by Kupffer cells and spleen macrophages, respectively [4]. It is suggested that these tissue specific opsonins are responsible for distribution of intravenously injected liposomes in various organs of the reticuloendothelial system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1623013     DOI: 10.1016/0167-4889(92)90230-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

Review 1.  Drug transport to brain with targeted liposomes.

Authors:  Anita Schnyder; Jörg Huwyler
Journal:  NeuroRx       Date:  2005-01

2.  Antiangiogenic activity of sterically stabilized liposomes containing paclitaxel (SSL-PTX): in vitro and in vivo.

Authors:  Yue Huang; Xiao-Mei Chen; Bing-Xiang Zhao; Xi-Yu Ke; Bo-Jun Zhao; Xin Zhao; Ying Wang; Xuan Zhang; Qiang Zhang
Journal:  AAPS PharmSciTech       Date:  2010-05-05       Impact factor: 3.246

3.  Brain drug delivery of small molecules using immunoliposomes.

Authors:  J Huwyler; D Wu; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

4.  The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation.

Authors:  Ke-Fu Yu; Wei-Qiang Zhang; Li-Min Luo; Ping Song; Dan Li; Ruo Du; Wei Ren; Dan Huang; Wan-Liang Lu; Xuan Zhang; Qiang Zhang
Journal:  Int J Nanomedicine       Date:  2013-07-15

Review 5.  The pharmacological bases of the antiangiogenic activity of paclitaxel.

Authors:  Guido Bocci; Antonello Di Paolo; Romano Danesi
Journal:  Angiogenesis       Date:  2013-02-07       Impact factor: 9.596

Review 6.  Tumor targeting using liposomal antineoplastic drugs.

Authors:  Jörg Huwyler; Jürgen Drewe; Stephan Krähenbuhl
Journal:  Int J Nanomedicine       Date:  2008

7.  Opsonin-Deficient Nucleoproteic Corona Endows UnPEGylated Liposomes with Stealth Properties In Vivo.

Authors:  Francesca Giulimondi; Elisabetta Vulpis; Luca Digiacomo; Maria Valeria Giuli; Angelica Mancusi; Anna Laura Capriotti; Aldo Laganà; Andrea Cerrato; Riccardo Zenezini Chiozzi; Carmine Nicoletti; Heinz Amenitsch; Francesco Cardarelli; Laura Masuelli; Roberto Bei; Isabella Screpanti; Daniela Pozzi; Alessandra Zingoni; Saula Checquolo; Giulio Caracciolo
Journal:  ACS Nano       Date:  2022-01-18       Impact factor: 15.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.